Bibliography. Current world literature. Hypertension.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000375:Aging / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism; D000085962:Angiotensin-Converting Enzyme 2; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D009320:Atrial Natriuretic Factor / Q000378:metabolism; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism; D048909:Diabetes Complications / Q000503:physiopathology; D019332:Endothelin-1 / Q000378:metabolism; D015316:Genetic Therapy; D006321:Heart / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D010597:Pharmacogenetics; D012923:Social Class; D017673:Sodium Chloride, Dietary / Q000009:adverse effects; D013312:Stress, Physiological / Q000150:complications
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D063385:Cannabinoid Receptor Modulators; D019332:Endothelin-1; D017673:Sodium Chloride, Dietary; D000804:Angiotensin II; D009320:Atrial Natriuretic Factor; D007703:Peptidyl-Dipeptidase A; C000705307:ACE2 protein, human; D000085962:Angiotensin-Converting Enzyme 2